BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chiou LC, Fan SH, Chuang KC, Liao YY, Lee SZ. Pharmacological characterization of nociceptin/orphanin FQ receptors, a novel opioid receptor family, in the midbrain periaqueductal gray. Ann N Y Acad Sci 2004;1025:398-403. [PMID: 15542742 DOI: 10.1196/annals.1316.049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Chen YL, Li AH, Yeh TH, Chou AH, Wang HL. Nocistatin and nociceptin exert opposite effects on the excitability of central amygdala nucleus-periaqueductal gray projection neurons. Mol Cell Neurosci 2009;40:76-88. [PMID: 18930828 DOI: 10.1016/j.mcn.2008.09.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
2 Gerashchenko D, Horvath TL, Xie XS. Direct inhibition of hypocretin/orexin neurons in the lateral hypothalamus by nociceptin/orphanin FQ blocks stress-induced analgesia in rats. Neuropharmacology 2011;60:543-9. [PMID: 21195099 DOI: 10.1016/j.neuropharm.2010.12.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
3 Chen Y, Li A, Yeh T, Chou A, Weng Y, Wang H. Nocistatin excites rostral agranular insular cortex-periaqueductal gray projection neurons by enhancing transient receptor potential cation conductance via Gαq/11-PLC-protein kinase C pathway. Neuroscience 2010;168:226-39. [DOI: 10.1016/j.neuroscience.2010.03.054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
4 Gupta S, Kulhara P. Cellular and molecular mechanisms of drug dependence: An overview and update. Indian J Psychiatry 2007;49:85-90. [PMID: 20711388 DOI: 10.4103/0019-5545.33253] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
5 Thosani S, Jimenez C. Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Review of Endocrinology & Metabolism 2014;6:705-13. [DOI: 10.1586/eem.11.55] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Targowska-Duda KM, Ozawa A, Bertels Z, Cippitelli A, Marcus JL, Mielke-Maday HK, Zribi G, Rainey AN, Kieffer BL, Pradhan AA, Toll L. NOP receptor agonist attenuates nitroglycerin-induced migraine-like symptoms in mice. Neuropharmacology 2020;170:108029. [PMID: 32278976 DOI: 10.1016/j.neuropharm.2020.108029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Fichna J, Sobczak M, Mokrowiecka A, Cygankiewicz AI, Zakrzewski PK, Cenac N, Sałaga M, Timmermans JP, Vergnolle N, Małecka-Panas E, Krajewska WM, Storr M. Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. Neurogastroenterol Motil 2014;26:1539-50. [PMID: 25041572 DOI: 10.1111/nmo.12390] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
8 Scoto GM, Aricò G, Ronsisvalle S, Parenti C. Blockade of the nociceptin/orphanin FQ/NOP receptor system in the rat ventrolateral periaqueductal gray potentiates DAMGO analgesia. Peptides 2007;28:1441-6. [PMID: 17628212 DOI: 10.1016/j.peptides.2007.05.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
9 Lirk P, Fiegl H, Weber NC, Hollmann MW. Epigenetics in the perioperative period. Br J Pharmacol 2015;172:2748-55. [PMID: 25073649 DOI: 10.1111/bph.12865] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
10 Largent-Milnes TM, Vanderah TW. Recently patented and promising ORL-1 ligands: where have we been and where are we going? Expert Opin Ther Pat 2010;20:291-305. [PMID: 20180617 DOI: 10.1517/13543771003602004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
11 Chiou LC, Liao YY, Guerrini R, Calo' G. [Nphe1,Arg14,Lys15]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray. Eur J Pharmacol 2005;515:47-53. [PMID: 15896734 DOI: 10.1016/j.ejphar.2005.03.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]